This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …

Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic
and biological information in order to optimise the therapeutic benefit relative to the …

Background Coronavirus disease 2019 (Covid-19) pneumonia is often associated with
hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved and …

Background Acute exacerbations adversely affect patients with chronic obstructive pulmonary
disease (COPD). Macrolide antibiotics benefit patients with a variety of inflammatory …

Importance Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients
with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate …

Background The benefits of triple therapy for chronic obstructive pulmonary disease (COPD)
with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-…

Background Endobronchial valves that allow air to escape from a pulmonary lobe but not
enter it can induce a reduction in lobar volume that may thereby improve lung function and …

Objectives To evaluate the safety and physiologic response of inhaled nitric oxide (NO) in
patients with acute respiratory distress syndrome (ARDS). In addition, the effect of various …

Despite substantial progress in reducing the global impact of many non-communicable
diseases, including heart disease and cancer, morbidity and mortality due to chronic respiratory …

Comorbidities such as cardiac disease, diabetes mellitus, hypertension, osteoporosis, and
psychological disorders are commonly reported in patients with chronic obstructive …